A selective synthetic cannabinoid receptor(CB1R) agonist,….
Interestingly, CBC appears to fight inflammation without activating cannabinoid receptors.
They cling to cannabinoid receptors that are situated throughout the body and brain.
(An agonist means it activates the cannabinoid receptors).Combinations with other parts of speech
尽管CBC不直接激活大麻素受体,但已经显示其与身体中的许多其他受体相互作用。
Although CBC does not directly activate cannabinoid receptors, it has been shown to interact with a number of other receptors in the body.年,研究人员研究了大麻素受体对淋巴瘤细胞(MCL)的影响。
In 2005, researchers examined the effects of cannabinoid receptor activation on mantle cell lymphoma(MCL).虽然THC是“部分激动剂”(它只与大麻素受体部分反应),但合成大麻通常是“完全激动剂”。
While THC isa“partial agonist”(it only partially reacts with cannabinoid receptors), synthetic cannabis is often a“full agonist”.大麻素受体CB1和CB2由身体设计为THC的特异性靶标,而我们的天然内源性大麻素有助于其合成。
Cannabinoid receptors CB1 and CB2 are designed by the body to be specific targets for THC, while our natural endocannabinoids help to synthesize it.同时,研究人员还发现,用大麻素受体激动剂(WIN55,212)治疗可恢复MG小鼠的神经肌肉传递。
Researchers also found that treatment with a cannabinoid receptor agonist(WIN 55,212) restored neuromuscular transmission in the MG mice.这意味着任何会影响内源性大麻素水平或直接影响大麻素受体功能的物质都将不可避免地影响大脑发育。
This means that any substance that influences either endocannabinoid levels ordirectly affects cannabinoid receptor function will inevitably impinge upon brain development.它激活大麻素受体在大脑中,引起与大麻有关的“高”,以及在肝脏和身体的其他部位。
It activates cannabinoid receptors in the brain, causing the“high” associated with cannabis, as well as in the liver, and other parts of the body.关切含有合成大麻素受体激动剂的混合草药如Spice产品越来越多地通过不同渠道特别是经由互联网销售,.
Concerned that herbal mixtures containing cannabinoid receptor agonists, such as Spice products, are increasingly being sold through various channels, in particular through the Internet.
These cannabinoid receptors have an effect on several mental and physical activities, including:.已经表明,大麻素受体可以被靶向以减轻某些病理状况,包括慢性疼痛。
It has been shown that the cannabinoid receptors can be targeted to alleviate certain pathological conditions, including chronic pain.众所周知,激活大麻素受体1(CB1R)可能有助于暴饮暴食。
It is also well known that activating the cannabinoid receptor 1(CB1R) can contribute to overeating.NESS-0327是一种用于科学研究的药物,它作为大麻素受体CB1的一种极有效的选择性拮抗剂。
NESS-0327 is a drug used in scientific research which acts as an extremely potent andselective antagonist of the cannabinoid receptor CB1.它激活大麻素受体在大脑中,引起与大麻有关的“高”,以及在肝脏和身体的其他部位。
It activates cannabinoid receptors in the brain, causing the"high" related to marijuana, along with in the liver, and other parts of the body.合成大麻素受体激动剂具有与大麻类似的药效,可在世界上大部分区域获得。
Synthetic cannabinoid receptor agonists with cannabis-like effects are also available in most regions of the world.RimonabanthHydrochloride(SR141716AHydrochloride)是中心大麻素受体1(CB1)高效的、选择性的反向激动剂,Ki值为1.8nM。
Rimonabant hHydrochloride(SR 141716A Hydrochloride)is a highly potent and selective central cannabinoid receptor(CB1) antagonist with an Ki of 1.8 nM.
The locks are called cannabinoid receptors which are located throughout the brain and body.一个中国研究小组与俄罗斯和美国生物学家联手,获得了人类2型大麻素受体的晶体结构。
A Chinese research team joined forces with Russian and U.S. biologists to obtain thecrystal structure of the human type 2 cannabinoid receptor.当你消费时,你会淹没这些CB1大麻素受体,远远高于他们日常生活的治疗方法。
When you consume, you're flooding these CB1 cannabinoid receptors well above what they have evolved to be treated day-to-day.大麻素受体目前分为三类:中枢(CB1)、外周(CB2)和GPR55,它们都是G蛋白偶联的。
Cannabinoid receptors are currently classified into three groups: central(CB1), peripheral(CB2) and GPR55, all of which are G-protein-coupled.当四氢大麻酚激活大麻素受体时,它会影响这些大脑区域的正常功能。
When THC activates cannabinoid receptors, it effects the normal functioning of these brain areas.CBD和THC在化学上与人体内的内源性大麻素相似,这使他们能够与大麻素受体相互作用。
THC and CBD are similar chemically to thebody's own endocannabinoids allowing them to interact with your cannabinoid receptors.CBD和THC在化学上与人体内的内源性大麻素相似,这使他们能够与大麻素受体相互作用。
Both CBD and THC are chemically similar to the body's endocannabinoids,allowing them to interact with the body's cannabinoid receptors.国家癌症研究所的一份报告发现,低剂量的大麻素精油可以结合人体的大麻素受体,从而增加食欲。
A report by the National Cancer Institute found that low doses ofCBD oil can bind to the body's cannabinoid receptors, thereby increasing appetite.